How should a vaginal yeast infection be managed during a patient visit?

Management of Vaginal Yeast Infection

For uncomplicated vulvovaginal candidiasis, treat with either a single 150 mg oral dose of fluconazole OR a short course (1-7 days) of topical azole antifungals, with both options showing equivalent efficacy 1.

Diagnostic Approach

Confirm the diagnosis before treating. While many providers rely on clinical presentation alone, less than half of patients clinically diagnosed with VVC actually have the infection 1.

Recommended Diagnostic Methods:

• Culture remains the gold standard but requires 48-72 hours 1
• PCR/molecular testing is superior to microscopy with 90.9% sensitivity and 94.1% specificity for Candida group species (C. albicans, C. dubliniensis, C. parapsilosis, C. tropicalis) 1
• Microscopy has poor sensitivity (57.5%) and should not be relied upon alone 1
• Physical examination should focus on vulvovaginal erythema, white thick curd-like discharge, and pruritus 2, 1

Common pitfall: Treating based on symptoms alone leads to misdiagnosis and unnecessary antifungal use in over 50% of cases 1.

Classification: Uncomplicated vs Complicated

This distinction is critical as it determines treatment intensity 1:

Uncomplicated VVC:

• Mild-to-moderate symptoms
• Infrequent episodes
• C. albicans infection
• Non-immunocompromised host

Complicated VVC:

• Severe symptoms
• Recurrent episodes (≥4 per year)
• Non-albicans species (especially C. glabrata)
• Immunocompromised patients (diabetes, HIV, immunosuppressive therapy)

Treatment Regimens

For Uncomplicated VVC

Choose ONE of the following 1:

Oral Option:

• Fluconazole 150 mg single dose

Over-the-Counter Topical Options:

• Miconazole 1200 mg vaginal suppository (single dose)
• Tioconazole 6.5% ointment 5g (single application)
• Clotrimazole 2% cream 5g daily × 3 days
• Miconazole 4% cream 5g daily × 3 days

Prescription Topical Options:

• Butoconazole 2% cream 5g (single application, bioadhesive)
• Terconazole 0.8% cream 5g daily × 3 days

For Complicated VVC

Requires extended treatment duration 1, 3:

• Fluconazole 150 mg every 72 hours for 3 doses (days 1,4,7)
• OR topical azole therapy for 7-14 days
• Followed by maintenance therapy: Fluconazole 150 mg weekly for 6 months for recurrent cases

For Treatment Failures

If first-line therapy fails 3:

1. Reconsider the diagnosis - rule out bacterial vaginosis, trichomoniasis, desquamative inflammatory vaginitis, genitourinary syndrome of menopause
2. Vaginal boric acid 600 mg suppositories daily × 14 days (cheapest and easiest alternative) 3
3. Consider non-albicans species, particularly C. glabrata (lower PCR sensitivity at 75.9%, may require culture confirmation) 1
4. Test for fluconazole resistance if C. albicans confirmed 4

Key Clinical Considerations

Recurrent VVC (RVVC) affects up to 10% of women with ≥3 episodes per year 2. The mean duration of recurrent episodes is approximately 1.5 years 4.

Risk factors to assess:

• Diabetes mellitus
• Immunosuppression
• Antibiotic use
• Obesity
• Pregnancy

Important caveats:

• Probiotics are NOT recommended for VVC prevention 3
• Partner treatment is not indicated for VVC (unlike trichomoniasis) 5
• Some commercial PCR tests are not FDA-cleared; verify test validation 1
• C. glabrata has inherently reduced azole susceptibility and may require boric acid or alternative agents 1

For pregnant patients: Use only topical azoles for 7 days; avoid oral fluconazole due to teratogenicity concerns.